Global Peripheral Arterial Disease (PAD) Therapeutics Market Research Report 2025(Status and Outlook)
Report Overview
Peripheral artery disease (PAD) is a narrowing of the arteries other than those that supply the heart or the brain. When narrowing occurs in the heart, it is called coronary artery disease, while, in the brain, it is called cerebrovascular disease. Peripheral artery disease most commonly affects the legs, but other arteries may also be involved. The classic symptom is leg pain when walking which resolves with rest, known as intermittent claudication. Other symptoms including skin ulcers, bluish skin, cold skin, or poor nail and hair growth may occur in the affected leg. Complications may include an infection or tissue death which may require amputation; coronary artery disease, or stroke.[3] Up to 50% of cases of PAD are without symptoms.
This report provides a deep insight into the global Peripheral Arterial Disease (PAD) Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Peripheral Arterial Disease (PAD) Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Peripheral Arterial Disease (PAD) Therapeutics market in any manner.
Global Peripheral Arterial Disease (PAD) Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
AstraZeneca Plc. (UK)
Bayer HealthCare Pharmaceuticals (Germany)
Bristol-Myers Squibb Company (US)
Merck & Co.
Inc. (US)
Proteon Therapeutics
Inc. (US)
Sanofi S.A. (France)
Symic Bio
Inc. (US)
TheraVasc Inc. (US)
AnGes MG
Inc. (Japan)
Athersys
Inc. (US)
Betagenon AB (Sweden)
miRagen Therapeutics
Inc. (US)
Multi Gene Vascular Systems Ltd (Israel)
ViroMed Co. Ltd. (Korea)
Market Segmentation (by Type)
Anti-Platelet Drugs
Dual Antiplatelet Therapy Drugs
Others
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Peripheral Arterial Disease (PAD) Therapeutics Market
- Overview of the regional outlook of the Peripheral Arterial Disease (PAD) Therapeutics Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Peripheral Arterial Disease (PAD) Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Peripheral Arterial Disease (PAD) Therapeutics
1.2 Key Market Segments
1.2.1 Peripheral Arterial Disease (PAD) Therapeutics Segment by Type
1.2.2 Peripheral Arterial Disease (PAD) Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GLOBAL PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Peripheral Arterial Disease (PAD) Therapeutics Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GLOBAL PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Peripheral Arterial Disease (PAD) Therapeutics Product Life Cycle
3.3 Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Manufacturers (2020-2025)
3.4 Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Manufacturers (2020-2025)
3.5 Peripheral Arterial Disease (PAD) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Peripheral Arterial Disease (PAD) Therapeutics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Peripheral Arterial Disease (PAD) Therapeutics Manufacturing Sites, Area Served, Product Type
3.8 Peripheral Arterial Disease (PAD) Therapeutics Market Competitive Situation and Trends
3.8.1 Peripheral Arterial Disease (PAD) Therapeutics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Peripheral Arterial Disease (PAD) Therapeutics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Peripheral Arterial Disease (PAD) Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Peripheral Arterial Disease (PAD) Therapeutics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Peripheral Arterial Disease (PAD) Therapeutics Market
5.7 ESG Ratings of Leading Companies
6 GLOBAL PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET BY REGION
6.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region
6.1.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region
6.1.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Region
6.2 Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Region
6.2.1 Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Region
6.2.2 Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Region
7 NORTH AMERICA MARKET OVERVIEW
7.1 North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type
7.3 North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application
8 EUROPE MARKET OVERVIEW
8.1 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type
8.3 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application
9 ASIA-PACIFIC MARKET OVERVIEW
9.1 Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type
9.3 Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application
10 SOUTH AMERICA MARKET OVERVIEW
10.1 South America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type
10.3 South America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application
11 MIDDLE EAST AND AFRICA MARKET OVERVIEW
11.1 Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type
11.3 Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application
12 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET PRODUCTION BY REGION
12.1 Global Production of Peripheral Arterial Disease (PAD) Therapeutics by Region(2020-2025)
12.2 Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Region (2020-2025)
12.3 Global Peripheral Arterial Disease (PAD) Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Peripheral Arterial Disease (PAD) Therapeutics Production
12.4.1 North America Peripheral Arterial Disease (PAD) Therapeutics Production Growth Rate (2020-2025)
12.4.2 North America Peripheral Arterial Disease (PAD) Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Peripheral Arterial Disease (PAD) Therapeutics Production
12.5.1 Europe Peripheral Arterial Disease (PAD) Therapeutics Production Growth Rate (2020-2025)
12.5.2 Europe Peripheral Arterial Disease (PAD) Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Peripheral Arterial Disease (PAD) Therapeutics Production (2020-2025)
12.6.1 Japan Peripheral Arterial Disease (PAD) Therapeutics Production Growth Rate (2020-2025)
12.6.2 Japan Peripheral Arterial Disease (PAD) Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Peripheral Arterial Disease (PAD) Therapeutics Production (2020-2025)
12.7.1 China Peripheral Arterial Disease (PAD) Therapeutics Production Growth Rate (2020-2025)
12.7.2 China Peripheral Arterial Disease (PAD) Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
13 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET SEGMENTATION BY TYPE
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Type (2020-2033)
13.3 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Type (2020-2033)
13.4 Global Peripheral Arterial Disease (PAD) Therapeutics Price by Type (2020-2033)
14 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Sales by Application (2020-2033)
14.3 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Application (2020-2033)
14.4 Global Peripheral Arterial Disease (PAD) Therapeutics Sales Growth Rate by Application (2020-2033)
15 KEY COMPANIES PROFILE
15.1 AstraZeneca Plc. (UK)
15.1.1 AstraZeneca Plc. (UK) Basic Information
15.1.2 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
15.1.3 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
15.1.4 AstraZeneca Plc. (UK) Business Overview
15.1.5 AstraZeneca Plc. (UK) SWOT Analysis
15.1.6 AstraZeneca Plc. (UK) Recent Developments
15.2 Bayer HealthCare Pharmaceuticals (Germany)
15.2.1 Bayer HealthCare Pharmaceuticals (Germany) Basic Information
15.2.2 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
15.2.3 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
15.2.4 Bayer HealthCare Pharmaceuticals (Germany) Business Overview
15.2.5 Bayer HealthCare Pharmaceuticals (Germany) SWOT Analysis
15.2.6 Bayer HealthCare Pharmaceuticals (Germany) Recent Developments
15.3 Bristol-Myers Squibb Company (US)
15.3.1 Bristol-Myers Squibb Company (US) Basic Information
15.3.2 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
15.3.3 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
15.3.4 Bristol-Myers Squibb Company (US) Business Overview
15.3.5 Bristol-Myers Squibb Company (US) SWOT Analysis
15.3.6 Bristol-Myers Squibb Company (US) Recent Developments
15.4 Merck and Co.
15.4.1 Merck and Co. Basic Information
15.4.2 Merck and Co. Peripheral Arterial Disease (PAD) Therapeutics Product Overview
15.4.3 Merck and Co. Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
15.4.4 Merck and Co. Business Overview
15.4.5 Merck and Co. Recent Developments
15.5 Inc. (US)
15.5.1 Inc. (US) Basic Information
15.5.2 Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
15.5.3 Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
15.5.4 Inc. (US) Business Overview
15.5.5 Inc. (US) Recent Developments
15.6 Proteon Therapeutics
15.6.1 Proteon Therapeutics Basic Information
15.6.2 Proteon Therapeutics Peripheral Arterial Disease (PAD) Therapeutics Product Overview
15.6.3 Proteon Therapeutics Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
15.6.4 Proteon Therapeutics Business Overview
15.6.5 Proteon Therapeutics Recent Developments
15.7 Inc. (US)
15.7.1 Inc. (US) Basic Information
15.7.2 Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
15.7.3 Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
15.7.4 Inc. (US) Business Overview
15.7.5 Inc. (US) Recent Developments
15.8 Sanofi S.A. (France)
15.8.1 Sanofi S.A. (France) Basic Information
15.8.2 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
15.8.3 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
15.8.4 Sanofi S.A. (France) Business Overview
15.8.5 Sanofi S.A. (France) Recent Developments
15.9 Symic Bio
15.9.1 Symic Bio Basic Information
15.9.2 Symic Bio Peripheral Arterial Disease (PAD) Therapeutics Product Overview
15.9.3 Symic Bio Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
15.9.4 Symic Bio Business Overview
15.9.5 Symic Bio Recent Developments
15.10 Inc. (US)
15.10.1 Inc. (US) Basic Information
15.10.2 Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
15.10.3 Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
15.10.4 Inc. (US) Business Overview
15.10.5 Inc. (US) Recent Developments
15.11 TheraVasc Inc. (US)
15.11.1 TheraVasc Inc. (US) Basic Information
15.11.2 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
15.11.3 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
15.11.4 TheraVasc Inc. (US) Business Overview
15.11.5 TheraVasc Inc. (US) Recent Developments
15.12 AnGes MG
15.12.1 AnGes MG Basic Information
15.12.2 AnGes MG Peripheral Arterial Disease (PAD) Therapeutics Product Overview
15.12.3 AnGes MG Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
15.12.4 AnGes MG Business Overview
15.12.5 AnGes MG Recent Developments
15.13 Inc. (Japan)
15.13.1 Inc. (Japan) Basic Information
15.13.2 Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
15.13.3 Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
15.13.4 Inc. (Japan) Business Overview
15.13.5 Inc. (Japan) Recent Developments
15.14 Athersys
15.14.1 Athersys Basic Information
15.14.2 Athersys Peripheral Arterial Disease (PAD) Therapeutics Product Overview
15.14.3 Athersys Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
15.14.4 Athersys Business Overview
15.14.5 Athersys Recent Developments
15.15 Inc. (US)
15.15.1 Inc. (US) Basic Information
15.15.2 Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
15.15.3 Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
15.15.4 Inc. (US) Business Overview
15.15.5 Inc. (US) Recent Developments
15.16 Betagenon AB (Sweden)
15.16.1 Betagenon AB (Sweden) Basic Information
15.16.2 Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
15.16.3 Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
15.16.4 Betagenon AB (Sweden) Business Overview
15.16.5 Betagenon AB (Sweden) Recent Developments
15.17 miRagen Therapeutics
15.17.1 miRagen Therapeutics Basic Information
15.17.2 miRagen Therapeutics Peripheral Arterial Disease (PAD) Therapeutics Product Overview
15.17.3 miRagen Therapeutics Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
15.17.4 miRagen Therapeutics Business Overview
15.17.5 miRagen Therapeutics Recent Developments
15.18 Inc. (US)
15.18.1 Inc. (US) Basic Information
15.18.2 Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
15.18.3 Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
15.18.4 Inc. (US) Business Overview
15.18.5 Inc. (US) Recent Developments
15.19 Multi Gene Vascular Systems Ltd (Israel)
15.19.1 Multi Gene Vascular Systems Ltd (Israel) Basic Information
15.19.2 Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
15.19.3 Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
15.19.4 Multi Gene Vascular Systems Ltd (Israel) Business Overview
15.19.5 Multi Gene Vascular Systems Ltd (Israel) Recent Developments
15.20 ViroMed Co. Ltd. (Korea)
15.20.1 ViroMed Co. Ltd. (Korea) Basic Information
15.20.2 ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
15.20.3 ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
15.20.4 ViroMed Co. Ltd. (Korea) Business Overview
15.20.5 ViroMed Co. Ltd. (Korea) Recent Developments
16 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (M USD)
Table 4. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (M USD)
Table 5. Peripheral Arterial Disease (PAD) Therapeutics Market Size Comparison by Region (M USD)
Table 6. Global Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Arterial Disease (PAD) Therapeutics as of 2024)
Table 11. Global Market Peripheral Arterial Disease (PAD) Therapeutics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Peripheral Arterial Disease (PAD) Therapeutics Manufacturing Sites and Area Served
Table 13. Manufacturers Peripheral Arterial Disease (PAD) Therapeutics Product Type
Table 14. Global Peripheral Arterial Disease (PAD) Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Peripheral Arterial Disease (PAD) Therapeutics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Peripheral Arterial Disease (PAD) Therapeutics Market Size Comparison by Region (M USD)
Table 26. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region (2020-2033) & (M USD)
Table 27. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Region (2020-2033)
Table 28. Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Region (2020-2033) & (K Units)
Table 29. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Region (2020-2033)
Table 30. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2020-2033) & (M USD)
Table 31. North America Peripheral Arterial Disease (PAD) Therapeutics Sales by Country (2020-2033) & (K Units)
Table 32. North America Peripheral Arterial Disease (PAD) Therapeutics Sales by Type (K Units)
Table 33. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (M USD)
Table 34. North America Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Type (2020-2033)
Table 35. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Type (2020-2033)
Table 36. North America Peripheral Arterial Disease (PAD) Therapeutics Sales by Application (K Units)
Table 37. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (M USD)
Table 38. North America Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Application (2020-2033)
Table 39. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Application (2020-2033)
Table 40. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Peripheral Arterial Disease (PAD) Therapeutics Sales by Country (2020-2033) & (K Units)
Table 42. Europe Peripheral Arterial Disease (PAD) Therapeutics Sales by Type (K Units)
Table 43. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (M USD)
Table 44. Europe Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Type (2020-2033)
Table 45. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Type (2020-2033)
Table 46. Europe Peripheral Arterial Disease (PAD) Therapeutics Sales by Application (K Units)
Table 47. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (M USD)
Table 48. Europe Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Application (2020-2033)
Table 49. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Sales by Country (2020-2025) & (K Units)
Table 52. Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Sales by Type (K Units)
Table 53. Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (M USD)
Table 54. Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Type (2020-2033)
Table 55. Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Sales by Application (K Units)
Table 57. Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (M USD)
Table 58. Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Application (2020-2033)
Table 59. Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Application (2020-2025)
Table 60. South America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2020-2033) & (M USD)
Table 61. South America Peripheral Arterial Disease (PAD) Therapeutics Sales by Country (2020-2033) & (K Units)
Table 62. South America Peripheral Arterial Disease (PAD) Therapeutics Sales by Type (K Units)
Table 63. South America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (M USD)
Table 64. South America Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Type (2020-2033)
Table 65. South America Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Type (2020-2033)
Table 66. South America Peripheral Arterial Disease (PAD) Therapeutics Sales by Application (K Units)
Table 67. South America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (M USD)
Table 68. South America Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Application (2020-2033)
Table 69. South America Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Sales by Country (2020-2033) & (K Units)
Table 72. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Sales by Type (K Units)
Table 73. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (M USD)
Table 74. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Type (2020-2033)
Table 75. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Sales by Application (K Units)
Table 77. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (M USD)
Table 78. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Application (2020-2033)
Table 79. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Application (2020-2033)
Table 80. Global Peripheral Arterial Disease (PAD) Therapeutics Production (K Units) by Region(2020-2025)
Table 81. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Region (2020-2025)
Table 83. Global Peripheral Arterial Disease (PAD) Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 84. North America Peripheral Arterial Disease (PAD) Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Europe Peripheral Arterial Disease (PAD) Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Japan Peripheral Arterial Disease (PAD) Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. China Peripheral Arterial Disease (PAD) Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Type (K Units)
Table 89. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (M USD)
Table 90. Global Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Type (2020-2033)
Table 91. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Type (2020-2033)
Table 92. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Type (2020-2033)
Table 93. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Type (2020-2033)
Table 94. Global Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Application
Table 95. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application(M USD)
Table 96. Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Application (2020-2033) & (K Units)
Table 97. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Application (2020-2033)
Table 98. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2020-2033) & (M USD)
Table 99. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2020-2033)
Table 100. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Growth Rate by Application (2020-2033)
Table 101. AstraZeneca Plc. (UK) Basic Information
Table 102. AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 103. AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 104. AstraZeneca Plc. (UK) Business Overview
Table 105. AstraZeneca Plc. (UK) SWOT Analysis
Table 106. AstraZeneca Plc. (UK) Recent Developments
Table 107. Bayer HealthCare Pharmaceuticals (Germany) Basic Information
Table 108. Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 109. Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Bayer HealthCare Pharmaceuticals (Germany) Business Overview
Table 111. Bayer HealthCare Pharmaceuticals (Germany) SWOT Analysis
Table 112. Bayer HealthCare Pharmaceuticals (Germany) Recent Developments
Table 113. Bristol-Myers Squibb Company (US) Basic Information
Table 114. Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 115. Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Bristol-Myers Squibb Company (US) Business Overview
Table 117. Bristol-Myers Squibb Company (US) SWOT Analysis
Table 118. Bristol-Myers Squibb Company (US) Recent Developments
Table 119. Merck and Co. Basic Information
Table 120. Merck and Co. Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 121. Merck and Co. Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Merck and Co. Business Overview
Table 123. Merck and Co. Recent Developments
Table 124. Inc. (US) Basic Information
Table 125. Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 126. Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Inc. (US) Business Overview
Table 128. Inc. (US) Recent Developments
Table 129. Proteon Therapeutics Basic Information
Table 130. Proteon Therapeutics Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 131. Proteon Therapeutics Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Proteon Therapeutics Business Overview
Table 133. Proteon Therapeutics Recent Developments
Table 134. Inc. (US) Basic Information
Table 135. Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 136. Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Inc. (US) Business Overview
Table 138. Inc. (US) Recent Developments
Table 139. Sanofi S.A. (France) Basic Information
Table 140. Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 141. Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Sanofi S.A. (France) Business Overview
Table 143. Sanofi S.A. (France) Recent Developments
Table 144. Symic Bio Basic Information
Table 145. Symic Bio Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 146. Symic Bio Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 147. Symic Bio Business Overview
Table 148. Symic Bio Recent Developments
Table 149. Inc. (US) Basic Information
Table 150. Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 151. Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 152. Inc. (US) Business Overview
Table 153. Inc. (US) Recent Developments
Table 154. TheraVasc Inc. (US) Basic Information
Table 155. TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 156. TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 157. TheraVasc Inc. (US) Business Overview
Table 158. TheraVasc Inc. (US) Recent Developments
Table 159. AnGes MG Basic Information
Table 160. AnGes MG Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 161. AnGes MG Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 162. AnGes MG Business Overview
Table 163. AnGes MG Recent Developments
Table 164. Inc. (Japan) Basic Information
Table 165. Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 166. Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 167. Inc. (Japan) Business Overview
Table 168. Inc. (Japan) Recent Developments
Table 169. Athersys Basic Information
Table 170. Athersys Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 171. Athersys Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 172. Athersys Business Overview
Table 173. Athersys Recent Developments
Table 174. Inc. (US) Basic Information
Table 175. Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 176. Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 177. Inc. (US) Business Overview
Table 178. Inc. (US) Recent Developments
Table 179. Betagenon AB (Sweden) Basic Information
Table 180. Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 181. Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 182. Betagenon AB (Sweden) Business Overview
Table 183. Betagenon AB (Sweden) Recent Developments
Table 184. miRagen Therapeutics Basic Information
Table 185. miRagen Therapeutics Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 186. miRagen Therapeutics Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 187. miRagen Therapeutics Business Overview
Table 188. miRagen Therapeutics Recent Developments
Table 189. Inc. (US) Basic Information
Table 190. Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 191. Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 192. Inc. (US) Business Overview
Table 193. Inc. (US) Recent Developments
Table 194. Multi Gene Vascular Systems Ltd (Israel) Basic Information
Table 195. Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 196. Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 197. Multi Gene Vascular Systems Ltd (Israel) Business Overview
Table 198. Multi Gene Vascular Systems Ltd (Israel) Recent Developments
Table 199. ViroMed Co. Ltd. (Korea) Basic Information
Table 200. ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 201. ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 202. ViroMed Co. Ltd. (Korea) Business Overview
Table 203. ViroMed Co. Ltd. (Korea) Recent Developments
List of Figures
Figure 1. Product Picture of Peripheral Arterial Disease (PAD) Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD), 2024-2033
Figure 5. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) (2020-2033)
Figure 6. Global Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Peripheral Arterial Disease (PAD) Therapeutics Product Life Cycle
Figure 13. Peripheral Arterial Disease (PAD) Therapeutics Sales Share by Manufacturers in 2024
Figure 14. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Share by Manufacturers in 2024
Figure 15. Peripheral Arterial Disease (PAD) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Peripheral Arterial Disease (PAD) Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Peripheral Arterial Disease (PAD) Therapeutics Revenue in 2024
Figure 18. Industry Chain Map of Peripheral Arterial Disease (PAD) Therapeutics
Figure 19. Global Peripheral Arterial Disease (PAD) Therapeutics Market PEST Analysis
Figure 20. Global Peripheral Arterial Disease (PAD) Therapeutics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region
Figure 27. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Region (2020-2033)
Figure 28. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 31. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Country
Figure 33. USA Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 34. USA Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) and Growth Rate (2020-2033)
Figure 36. Canada Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Peripheral Arterial Disease (PAD) Therapeutics Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD)by Type
Figure 40. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 43. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Country
Figure 45. Germany Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 46. Germany Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 48. France Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 50. U.K. Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 52. Italy Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 54. Spain Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Type
Figure 56. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 59. Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Country
Figure 61. China Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. China Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Japan Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 66. South Korea Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 68. India Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 70. Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Type
Figure 72. Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 75. South America Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Country
Figure 77. Brazil Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 78. Brazil Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 80. Argentina Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 82. Columbia Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Type
Figure 84. South America Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 87. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Country
Figure 89. Saudi Arabia Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 90. Saudi Arabia Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 92. UAE Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 94. Egypt Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 96. Nigeria Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 98. South Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Type
Figure 100. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Application
Figure 101. Global Peripheral Arterial Disease (PAD) Therapeutics Production Market Share by Region (2020-2025)
Figure 102. North America Peripheral Arterial Disease (PAD) Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 103. Europe Peripheral Arterial Disease (PAD) Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 104. Japan Peripheral Arterial Disease (PAD) Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 105. China Peripheral Arterial Disease (PAD) Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (M USD)
Figure 108. Sales Market Share of Peripheral Arterial Disease (PAD) Therapeutics by Type (2020-2033)
Figure 109. Sales Market Share of Peripheral Arterial Disease (PAD) Therapeutics by Type in 2024
Figure 110. Market Size Share of Peripheral Arterial Disease (PAD) Therapeutics by Type (2020-2033)
Figure 111. Market Size Share of Peripheral Arterial Disease (PAD) Therapeutics by Type in 2024
Figure 112. Global Peripheral Arterial Disease (PAD) Therapeutics Price (USD/Unit) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application(M USD)
Figure 115. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application
Figure 116. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Application (2020-2033)
Figure 117. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Application in 2024
Figure 118. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2020-2033)
Figure 119. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application in 2024
Figure 120. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Growth Rate by Application (2020-2033)
1.1 Market Definition and Statistical Scope of Peripheral Arterial Disease (PAD) Therapeutics
1.2 Key Market Segments
1.2.1 Peripheral Arterial Disease (PAD) Therapeutics Segment by Type
1.2.2 Peripheral Arterial Disease (PAD) Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GLOBAL PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Peripheral Arterial Disease (PAD) Therapeutics Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GLOBAL PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Peripheral Arterial Disease (PAD) Therapeutics Product Life Cycle
3.3 Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Manufacturers (2020-2025)
3.4 Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Manufacturers (2020-2025)
3.5 Peripheral Arterial Disease (PAD) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Peripheral Arterial Disease (PAD) Therapeutics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Peripheral Arterial Disease (PAD) Therapeutics Manufacturing Sites, Area Served, Product Type
3.8 Peripheral Arterial Disease (PAD) Therapeutics Market Competitive Situation and Trends
3.8.1 Peripheral Arterial Disease (PAD) Therapeutics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Peripheral Arterial Disease (PAD) Therapeutics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Peripheral Arterial Disease (PAD) Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Peripheral Arterial Disease (PAD) Therapeutics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Peripheral Arterial Disease (PAD) Therapeutics Market
5.7 ESG Ratings of Leading Companies
6 GLOBAL PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET BY REGION
6.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region
6.1.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region
6.1.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Region
6.2 Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Region
6.2.1 Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Region
6.2.2 Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Region
7 NORTH AMERICA MARKET OVERVIEW
7.1 North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type
7.3 North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application
8 EUROPE MARKET OVERVIEW
8.1 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type
8.3 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application
9 ASIA-PACIFIC MARKET OVERVIEW
9.1 Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type
9.3 Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application
10 SOUTH AMERICA MARKET OVERVIEW
10.1 South America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type
10.3 South America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application
11 MIDDLE EAST AND AFRICA MARKET OVERVIEW
11.1 Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type
11.3 Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application
12 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET PRODUCTION BY REGION
12.1 Global Production of Peripheral Arterial Disease (PAD) Therapeutics by Region(2020-2025)
12.2 Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Region (2020-2025)
12.3 Global Peripheral Arterial Disease (PAD) Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Peripheral Arterial Disease (PAD) Therapeutics Production
12.4.1 North America Peripheral Arterial Disease (PAD) Therapeutics Production Growth Rate (2020-2025)
12.4.2 North America Peripheral Arterial Disease (PAD) Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Peripheral Arterial Disease (PAD) Therapeutics Production
12.5.1 Europe Peripheral Arterial Disease (PAD) Therapeutics Production Growth Rate (2020-2025)
12.5.2 Europe Peripheral Arterial Disease (PAD) Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Peripheral Arterial Disease (PAD) Therapeutics Production (2020-2025)
12.6.1 Japan Peripheral Arterial Disease (PAD) Therapeutics Production Growth Rate (2020-2025)
12.6.2 Japan Peripheral Arterial Disease (PAD) Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Peripheral Arterial Disease (PAD) Therapeutics Production (2020-2025)
12.7.1 China Peripheral Arterial Disease (PAD) Therapeutics Production Growth Rate (2020-2025)
12.7.2 China Peripheral Arterial Disease (PAD) Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
13 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET SEGMENTATION BY TYPE
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Type (2020-2033)
13.3 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Type (2020-2033)
13.4 Global Peripheral Arterial Disease (PAD) Therapeutics Price by Type (2020-2033)
14 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Sales by Application (2020-2033)
14.3 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Application (2020-2033)
14.4 Global Peripheral Arterial Disease (PAD) Therapeutics Sales Growth Rate by Application (2020-2033)
15 KEY COMPANIES PROFILE
15.1 AstraZeneca Plc. (UK)
15.1.1 AstraZeneca Plc. (UK) Basic Information
15.1.2 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
15.1.3 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
15.1.4 AstraZeneca Plc. (UK) Business Overview
15.1.5 AstraZeneca Plc. (UK) SWOT Analysis
15.1.6 AstraZeneca Plc. (UK) Recent Developments
15.2 Bayer HealthCare Pharmaceuticals (Germany)
15.2.1 Bayer HealthCare Pharmaceuticals (Germany) Basic Information
15.2.2 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
15.2.3 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
15.2.4 Bayer HealthCare Pharmaceuticals (Germany) Business Overview
15.2.5 Bayer HealthCare Pharmaceuticals (Germany) SWOT Analysis
15.2.6 Bayer HealthCare Pharmaceuticals (Germany) Recent Developments
15.3 Bristol-Myers Squibb Company (US)
15.3.1 Bristol-Myers Squibb Company (US) Basic Information
15.3.2 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
15.3.3 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
15.3.4 Bristol-Myers Squibb Company (US) Business Overview
15.3.5 Bristol-Myers Squibb Company (US) SWOT Analysis
15.3.6 Bristol-Myers Squibb Company (US) Recent Developments
15.4 Merck and Co.
15.4.1 Merck and Co. Basic Information
15.4.2 Merck and Co. Peripheral Arterial Disease (PAD) Therapeutics Product Overview
15.4.3 Merck and Co. Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
15.4.4 Merck and Co. Business Overview
15.4.5 Merck and Co. Recent Developments
15.5 Inc. (US)
15.5.1 Inc. (US) Basic Information
15.5.2 Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
15.5.3 Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
15.5.4 Inc. (US) Business Overview
15.5.5 Inc. (US) Recent Developments
15.6 Proteon Therapeutics
15.6.1 Proteon Therapeutics Basic Information
15.6.2 Proteon Therapeutics Peripheral Arterial Disease (PAD) Therapeutics Product Overview
15.6.3 Proteon Therapeutics Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
15.6.4 Proteon Therapeutics Business Overview
15.6.5 Proteon Therapeutics Recent Developments
15.7 Inc. (US)
15.7.1 Inc. (US) Basic Information
15.7.2 Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
15.7.3 Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
15.7.4 Inc. (US) Business Overview
15.7.5 Inc. (US) Recent Developments
15.8 Sanofi S.A. (France)
15.8.1 Sanofi S.A. (France) Basic Information
15.8.2 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
15.8.3 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
15.8.4 Sanofi S.A. (France) Business Overview
15.8.5 Sanofi S.A. (France) Recent Developments
15.9 Symic Bio
15.9.1 Symic Bio Basic Information
15.9.2 Symic Bio Peripheral Arterial Disease (PAD) Therapeutics Product Overview
15.9.3 Symic Bio Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
15.9.4 Symic Bio Business Overview
15.9.5 Symic Bio Recent Developments
15.10 Inc. (US)
15.10.1 Inc. (US) Basic Information
15.10.2 Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
15.10.3 Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
15.10.4 Inc. (US) Business Overview
15.10.5 Inc. (US) Recent Developments
15.11 TheraVasc Inc. (US)
15.11.1 TheraVasc Inc. (US) Basic Information
15.11.2 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
15.11.3 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
15.11.4 TheraVasc Inc. (US) Business Overview
15.11.5 TheraVasc Inc. (US) Recent Developments
15.12 AnGes MG
15.12.1 AnGes MG Basic Information
15.12.2 AnGes MG Peripheral Arterial Disease (PAD) Therapeutics Product Overview
15.12.3 AnGes MG Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
15.12.4 AnGes MG Business Overview
15.12.5 AnGes MG Recent Developments
15.13 Inc. (Japan)
15.13.1 Inc. (Japan) Basic Information
15.13.2 Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
15.13.3 Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
15.13.4 Inc. (Japan) Business Overview
15.13.5 Inc. (Japan) Recent Developments
15.14 Athersys
15.14.1 Athersys Basic Information
15.14.2 Athersys Peripheral Arterial Disease (PAD) Therapeutics Product Overview
15.14.3 Athersys Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
15.14.4 Athersys Business Overview
15.14.5 Athersys Recent Developments
15.15 Inc. (US)
15.15.1 Inc. (US) Basic Information
15.15.2 Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
15.15.3 Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
15.15.4 Inc. (US) Business Overview
15.15.5 Inc. (US) Recent Developments
15.16 Betagenon AB (Sweden)
15.16.1 Betagenon AB (Sweden) Basic Information
15.16.2 Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
15.16.3 Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
15.16.4 Betagenon AB (Sweden) Business Overview
15.16.5 Betagenon AB (Sweden) Recent Developments
15.17 miRagen Therapeutics
15.17.1 miRagen Therapeutics Basic Information
15.17.2 miRagen Therapeutics Peripheral Arterial Disease (PAD) Therapeutics Product Overview
15.17.3 miRagen Therapeutics Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
15.17.4 miRagen Therapeutics Business Overview
15.17.5 miRagen Therapeutics Recent Developments
15.18 Inc. (US)
15.18.1 Inc. (US) Basic Information
15.18.2 Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
15.18.3 Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
15.18.4 Inc. (US) Business Overview
15.18.5 Inc. (US) Recent Developments
15.19 Multi Gene Vascular Systems Ltd (Israel)
15.19.1 Multi Gene Vascular Systems Ltd (Israel) Basic Information
15.19.2 Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
15.19.3 Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
15.19.4 Multi Gene Vascular Systems Ltd (Israel) Business Overview
15.19.5 Multi Gene Vascular Systems Ltd (Israel) Recent Developments
15.20 ViroMed Co. Ltd. (Korea)
15.20.1 ViroMed Co. Ltd. (Korea) Basic Information
15.20.2 ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
15.20.3 ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
15.20.4 ViroMed Co. Ltd. (Korea) Business Overview
15.20.5 ViroMed Co. Ltd. (Korea) Recent Developments
16 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (M USD)
Table 4. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (M USD)
Table 5. Peripheral Arterial Disease (PAD) Therapeutics Market Size Comparison by Region (M USD)
Table 6. Global Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Arterial Disease (PAD) Therapeutics as of 2024)
Table 11. Global Market Peripheral Arterial Disease (PAD) Therapeutics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Peripheral Arterial Disease (PAD) Therapeutics Manufacturing Sites and Area Served
Table 13. Manufacturers Peripheral Arterial Disease (PAD) Therapeutics Product Type
Table 14. Global Peripheral Arterial Disease (PAD) Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Peripheral Arterial Disease (PAD) Therapeutics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Peripheral Arterial Disease (PAD) Therapeutics Market Size Comparison by Region (M USD)
Table 26. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region (2020-2033) & (M USD)
Table 27. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Region (2020-2033)
Table 28. Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Region (2020-2033) & (K Units)
Table 29. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Region (2020-2033)
Table 30. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2020-2033) & (M USD)
Table 31. North America Peripheral Arterial Disease (PAD) Therapeutics Sales by Country (2020-2033) & (K Units)
Table 32. North America Peripheral Arterial Disease (PAD) Therapeutics Sales by Type (K Units)
Table 33. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (M USD)
Table 34. North America Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Type (2020-2033)
Table 35. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Type (2020-2033)
Table 36. North America Peripheral Arterial Disease (PAD) Therapeutics Sales by Application (K Units)
Table 37. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (M USD)
Table 38. North America Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Application (2020-2033)
Table 39. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Application (2020-2033)
Table 40. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Peripheral Arterial Disease (PAD) Therapeutics Sales by Country (2020-2033) & (K Units)
Table 42. Europe Peripheral Arterial Disease (PAD) Therapeutics Sales by Type (K Units)
Table 43. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (M USD)
Table 44. Europe Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Type (2020-2033)
Table 45. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Type (2020-2033)
Table 46. Europe Peripheral Arterial Disease (PAD) Therapeutics Sales by Application (K Units)
Table 47. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (M USD)
Table 48. Europe Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Application (2020-2033)
Table 49. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Sales by Country (2020-2025) & (K Units)
Table 52. Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Sales by Type (K Units)
Table 53. Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (M USD)
Table 54. Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Type (2020-2033)
Table 55. Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Sales by Application (K Units)
Table 57. Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (M USD)
Table 58. Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Application (2020-2033)
Table 59. Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Application (2020-2025)
Table 60. South America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2020-2033) & (M USD)
Table 61. South America Peripheral Arterial Disease (PAD) Therapeutics Sales by Country (2020-2033) & (K Units)
Table 62. South America Peripheral Arterial Disease (PAD) Therapeutics Sales by Type (K Units)
Table 63. South America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (M USD)
Table 64. South America Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Type (2020-2033)
Table 65. South America Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Type (2020-2033)
Table 66. South America Peripheral Arterial Disease (PAD) Therapeutics Sales by Application (K Units)
Table 67. South America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (M USD)
Table 68. South America Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Application (2020-2033)
Table 69. South America Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Sales by Country (2020-2033) & (K Units)
Table 72. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Sales by Type (K Units)
Table 73. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (M USD)
Table 74. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Type (2020-2033)
Table 75. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Sales by Application (K Units)
Table 77. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (M USD)
Table 78. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Application (2020-2033)
Table 79. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Application (2020-2033)
Table 80. Global Peripheral Arterial Disease (PAD) Therapeutics Production (K Units) by Region(2020-2025)
Table 81. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Region (2020-2025)
Table 83. Global Peripheral Arterial Disease (PAD) Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 84. North America Peripheral Arterial Disease (PAD) Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Europe Peripheral Arterial Disease (PAD) Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Japan Peripheral Arterial Disease (PAD) Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. China Peripheral Arterial Disease (PAD) Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Type (K Units)
Table 89. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (M USD)
Table 90. Global Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Type (2020-2033)
Table 91. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Type (2020-2033)
Table 92. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Type (2020-2033)
Table 93. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Type (2020-2033)
Table 94. Global Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Application
Table 95. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application(M USD)
Table 96. Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Application (2020-2033) & (K Units)
Table 97. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Application (2020-2033)
Table 98. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2020-2033) & (M USD)
Table 99. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2020-2033)
Table 100. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Growth Rate by Application (2020-2033)
Table 101. AstraZeneca Plc. (UK) Basic Information
Table 102. AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 103. AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 104. AstraZeneca Plc. (UK) Business Overview
Table 105. AstraZeneca Plc. (UK) SWOT Analysis
Table 106. AstraZeneca Plc. (UK) Recent Developments
Table 107. Bayer HealthCare Pharmaceuticals (Germany) Basic Information
Table 108. Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 109. Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Bayer HealthCare Pharmaceuticals (Germany) Business Overview
Table 111. Bayer HealthCare Pharmaceuticals (Germany) SWOT Analysis
Table 112. Bayer HealthCare Pharmaceuticals (Germany) Recent Developments
Table 113. Bristol-Myers Squibb Company (US) Basic Information
Table 114. Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 115. Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Bristol-Myers Squibb Company (US) Business Overview
Table 117. Bristol-Myers Squibb Company (US) SWOT Analysis
Table 118. Bristol-Myers Squibb Company (US) Recent Developments
Table 119. Merck and Co. Basic Information
Table 120. Merck and Co. Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 121. Merck and Co. Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Merck and Co. Business Overview
Table 123. Merck and Co. Recent Developments
Table 124. Inc. (US) Basic Information
Table 125. Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 126. Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Inc. (US) Business Overview
Table 128. Inc. (US) Recent Developments
Table 129. Proteon Therapeutics Basic Information
Table 130. Proteon Therapeutics Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 131. Proteon Therapeutics Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Proteon Therapeutics Business Overview
Table 133. Proteon Therapeutics Recent Developments
Table 134. Inc. (US) Basic Information
Table 135. Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 136. Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Inc. (US) Business Overview
Table 138. Inc. (US) Recent Developments
Table 139. Sanofi S.A. (France) Basic Information
Table 140. Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 141. Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Sanofi S.A. (France) Business Overview
Table 143. Sanofi S.A. (France) Recent Developments
Table 144. Symic Bio Basic Information
Table 145. Symic Bio Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 146. Symic Bio Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 147. Symic Bio Business Overview
Table 148. Symic Bio Recent Developments
Table 149. Inc. (US) Basic Information
Table 150. Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 151. Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 152. Inc. (US) Business Overview
Table 153. Inc. (US) Recent Developments
Table 154. TheraVasc Inc. (US) Basic Information
Table 155. TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 156. TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 157. TheraVasc Inc. (US) Business Overview
Table 158. TheraVasc Inc. (US) Recent Developments
Table 159. AnGes MG Basic Information
Table 160. AnGes MG Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 161. AnGes MG Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 162. AnGes MG Business Overview
Table 163. AnGes MG Recent Developments
Table 164. Inc. (Japan) Basic Information
Table 165. Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 166. Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 167. Inc. (Japan) Business Overview
Table 168. Inc. (Japan) Recent Developments
Table 169. Athersys Basic Information
Table 170. Athersys Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 171. Athersys Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 172. Athersys Business Overview
Table 173. Athersys Recent Developments
Table 174. Inc. (US) Basic Information
Table 175. Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 176. Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 177. Inc. (US) Business Overview
Table 178. Inc. (US) Recent Developments
Table 179. Betagenon AB (Sweden) Basic Information
Table 180. Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 181. Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 182. Betagenon AB (Sweden) Business Overview
Table 183. Betagenon AB (Sweden) Recent Developments
Table 184. miRagen Therapeutics Basic Information
Table 185. miRagen Therapeutics Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 186. miRagen Therapeutics Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 187. miRagen Therapeutics Business Overview
Table 188. miRagen Therapeutics Recent Developments
Table 189. Inc. (US) Basic Information
Table 190. Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 191. Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 192. Inc. (US) Business Overview
Table 193. Inc. (US) Recent Developments
Table 194. Multi Gene Vascular Systems Ltd (Israel) Basic Information
Table 195. Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 196. Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 197. Multi Gene Vascular Systems Ltd (Israel) Business Overview
Table 198. Multi Gene Vascular Systems Ltd (Israel) Recent Developments
Table 199. ViroMed Co. Ltd. (Korea) Basic Information
Table 200. ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 201. ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 202. ViroMed Co. Ltd. (Korea) Business Overview
Table 203. ViroMed Co. Ltd. (Korea) Recent Developments
List of Figures
Figure 1. Product Picture of Peripheral Arterial Disease (PAD) Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD), 2024-2033
Figure 5. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) (2020-2033)
Figure 6. Global Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Peripheral Arterial Disease (PAD) Therapeutics Product Life Cycle
Figure 13. Peripheral Arterial Disease (PAD) Therapeutics Sales Share by Manufacturers in 2024
Figure 14. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Share by Manufacturers in 2024
Figure 15. Peripheral Arterial Disease (PAD) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Peripheral Arterial Disease (PAD) Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Peripheral Arterial Disease (PAD) Therapeutics Revenue in 2024
Figure 18. Industry Chain Map of Peripheral Arterial Disease (PAD) Therapeutics
Figure 19. Global Peripheral Arterial Disease (PAD) Therapeutics Market PEST Analysis
Figure 20. Global Peripheral Arterial Disease (PAD) Therapeutics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region
Figure 27. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Region (2020-2033)
Figure 28. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 31. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Country
Figure 33. USA Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 34. USA Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) and Growth Rate (2020-2033)
Figure 36. Canada Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Peripheral Arterial Disease (PAD) Therapeutics Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD)by Type
Figure 40. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 43. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Country
Figure 45. Germany Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 46. Germany Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 48. France Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 50. U.K. Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 52. Italy Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 54. Spain Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Type
Figure 56. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 59. Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Country
Figure 61. China Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. China Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Japan Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 66. South Korea Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 68. India Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 70. Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Type
Figure 72. Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 75. South America Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Country
Figure 77. Brazil Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 78. Brazil Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 80. Argentina Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 82. Columbia Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Type
Figure 84. South America Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 87. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Country
Figure 89. Saudi Arabia Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 90. Saudi Arabia Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 92. UAE Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 94. Egypt Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 96. Nigeria Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 98. South Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Type
Figure 100. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Application
Figure 101. Global Peripheral Arterial Disease (PAD) Therapeutics Production Market Share by Region (2020-2025)
Figure 102. North America Peripheral Arterial Disease (PAD) Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 103. Europe Peripheral Arterial Disease (PAD) Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 104. Japan Peripheral Arterial Disease (PAD) Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 105. China Peripheral Arterial Disease (PAD) Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (M USD)
Figure 108. Sales Market Share of Peripheral Arterial Disease (PAD) Therapeutics by Type (2020-2033)
Figure 109. Sales Market Share of Peripheral Arterial Disease (PAD) Therapeutics by Type in 2024
Figure 110. Market Size Share of Peripheral Arterial Disease (PAD) Therapeutics by Type (2020-2033)
Figure 111. Market Size Share of Peripheral Arterial Disease (PAD) Therapeutics by Type in 2024
Figure 112. Global Peripheral Arterial Disease (PAD) Therapeutics Price (USD/Unit) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application(M USD)
Figure 115. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application
Figure 116. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Application (2020-2033)
Figure 117. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Application in 2024
Figure 118. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2020-2033)
Figure 119. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application in 2024
Figure 120. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Growth Rate by Application (2020-2033)
